SMAD2 and breast carcinoma: In TMEPAI knockdown cells, even though both Smad2 and Smad3 activities are enriched, the growth of breast cancer cells is inhibited (Figure 2E) suggesting that Smad2 transcriptional activity is dominant and growth inhibitory over Smad3 in the absence of TMEPAI.